OneMedNet Corporation (NASDAQ:ONMD), a commercial physical and biological research services company currently trading at $0.99 with a market capitalization of $27.7 million, has confirmed the ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...

Despite largely missing Ebitda and net profit compared to the street's estimate, brokerage firms continue to remain positive on the agrochemical stock in the long run.

Learn more about whether Ultragenyx Pharmaceutical Inc. or Vericel Corporation is a better investment based on AAII's A+ ...

News of a significant earnings beat propelled Regeneron Pharmaceuticals (NASDAQ: REGN) to a nearly 5% share price gain on the ...

Regeneron stock jumped Tuesday after the biotech giant topped Wall Street's December-quarter calls on the back of its cancer drug Libtayo.

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word (s): AGM/EGM SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items 04.02.2025 / 18:22 CET/CEST The issuer is ...

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema ...

Insider activity is seldom enough to move a market independently but can signal how a company’s management thinks. Exclusive content, detailed data sets, and best-in-class trade insights to ...